Item Type | Name |
Concept
|
Sodium-Potassium-Exchanging ATPase
|
Concept
|
Androgens
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
Concept
|
Angiotensins
|
Concept
|
Carbazoles
|
Concept
|
Albumins
|
Concept
|
Adenosine
|
Concept
|
Captopril
|
Concept
|
Biphenyl Compounds
|
Concept
|
Collagen
|
Concept
|
Cisplatin
|
Concept
|
Creatinine
|
Concept
|
Actins
|
Concept
|
Angiotensin II
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
Benzimidazoles
|
Concept
|
Clofibrate
|
Concept
|
Cyclic N-Oxides
|
Concept
|
Aminopeptidases
|
Concept
|
Antibodies
|
Concept
|
Desoxycorticosterone
|
Concept
|
Dextrans
|
Concept
|
Drug Implants
|
Concept
|
Hypolipidemic Agents
|
Concept
|
Amidines
|
Concept
|
Aminopyridines
|
Concept
|
Cyclic AMP
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
Concept
|
Antioxidants
|
Concept
|
Adamantane
|
Concept
|
Adenosine Triphosphate
|
Concept
|
Angiotensin I
|
Concept
|
Alprostadil
|
Concept
|
Amitrole
|
Concept
|
Antihypertensive Agents
|
Concept
|
Acetylcholine
|
Concept
|
Arachidonate Lipoxygenases
|
Concept
|
Anti-Inflammatory Agents
|
Concept
|
Arachidonic Acids
|
Concept
|
Amides
|
Concept
|
Estradiol
|
Concept
|
Fatty Acids, Monounsaturated
|
Concept
|
Furosemide
|
Concept
|
Cardiotonic Agents
|
Concept
|
Benzenesulfonates
|
Concept
|
Biological Factors
|
Concept
|
Benzoates
|
Concept
|
Fatty Acids
|
Concept
|
Cardiovascular Agents
|
Concept
|
Minerals
|
Concept
|
Drug Combinations
|
Concept
|
Cholesterol
|
Concept
|
Hydrogen Peroxide
|
Concept
|
Calcium Channel Blockers
|
Concept
|
Carrier Proteins
|
Concept
|
Enalapril
|
Concept
|
Aryl Hydrocarbon Hydroxylases
|
Concept
|
Chenodeoxycholic Acid
|
Concept
|
Delayed-Action Preparations
|
Concept
|
Base Sequence
|
Concept
|
Catalase
|
Concept
|
Fatty Acids, Unsaturated
|
Concept
|
Mineralocorticoids
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Diuretics
|
Concept
|
Follicle Stimulating Hormone
|
Concept
|
Protein Kinase C
|
Concept
|
Potassium Chloride
|
Concept
|
Hydroxyproline
|
Concept
|
Mixed Function Oxygenases
|
Concept
|
Prostaglandin-Endoperoxide Synthases
|
Concept
|
Hypnotics and Sedatives
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Reserpine
|
Concept
|
Membrane Proteins
|
Concept
|
Stereoisomerism
|
Concept
|
Tetraethylammonium Compounds
|
Concept
|
Lipoxygenase
|
Concept
|
Spin Labels
|
Concept
|
Sulfones
|
Concept
|
Oxygenases
|
Concept
|
8,11,14-Eicosatrienoic Acid
|
Concept
|
Triazoles
|
Concept
|
Growth Inhibitors
|
Concept
|
Renin
|
Concept
|
Inositol 1,4,5-Trisphosphate
|
Concept
|
Phenylurea Compounds
|
Concept
|
Sweetening Agents
|
Concept
|
Thiobarbituric Acid Reactive Substances
|
Concept
|
Oleic Acids
|
Concept
|
Isoenzymes
|
Concept
|
Testosterone
|
Concept
|
Urea
|
Concept
|
Oxadiazoles
|
Concept
|
Interleukin-6
|
Concept
|
Triglycerides
|
Concept
|
Superoxide Dismutase
|
Concept
|
Calcium
|
Concept
|
Receptor, Endothelin A
|
Concept
|
Oxamic Acid
|
Concept
|
Potassium, Dietary
|
Concept
|
Receptors, Tumor Necrosis Factor
|
Concept
|
Nitric Oxide
|
Concept
|
Potassium
|
Concept
|
Chemokine CCL2
|
Concept
|
NG-Nitroarginine Methyl Ester
|
Concept
|
Linoleic Acid
|
Concept
|
Peptide Fragments
|
Concept
|
Cell Adhesion Molecules
|
Concept
|
Glycogen Synthase Kinase 3
|
Concept
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
|
Concept
|
Cyclooxygenase 2
|
Concept
|
Receptors, CCR2
|
Concept
|
Valine
|
Concept
|
Eicosanoids
|
Concept
|
Pinacidil
|
Concept
|
Matrix Metalloproteinase 2
|
Concept
|
Diltiazem
|
Concept
|
Epoxide Hydrolases
|
Concept
|
Heme Oxygenase-1
|
Concept
|
Cyclooxygenase 2 Inhibitors
|
Concept
|
Fas Ligand Protein
|
Concept
|
Adenosine A2 Receptor Agonists
|
Concept
|
Receptors, CCR1
|
Concept
|
Neuroprotective Agents
|
Concept
|
Endothelin-1
|
Concept
|
Xanthines
|
Concept
|
3' Untranslated Regions
|
Concept
|
Leptin
|
Concept
|
Fibronectins
|
Concept
|
Cyclic GMP
|
Concept
|
Fenofibrate
|
Concept
|
Lauric Acids
|
Concept
|
Nitrites
|
Concept
|
Tetrazoles
|
Concept
|
Calcium Channels
|
Concept
|
NF-kappa B
|
Concept
|
PPAR gamma
|
Concept
|
Radiation-Protective Agents
|
Concept
|
RNA, Messenger
|
Concept
|
Sodium Chloride
|
Concept
|
Prostaglandins E, Synthetic
|
Concept
|
Receptor, Adenosine A1
|
Concept
|
Receptor, Angiotensin, Type 1
|
Concept
|
Angiotensin II Type 1 Receptor Blockers
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
Concept
|
Charybdotoxin
|
Concept
|
Chloride Channels
|
Concept
|
Receptors, Adrenergic, alpha-2
|
Concept
|
Osteopontin
|
Concept
|
Receptors, Purinergic P2X
|
Concept
|
Epithelial Sodium Channel Blockers
|
Concept
|
DNA Primers
|
Concept
|
Gallic Acid
|
Concept
|
Glucose
|
Concept
|
TRPV Cation Channels
|
Concept
|
Small Molecule Libraries
|
Concept
|
Uridine Triphosphate
|
Concept
|
Receptors, Cytoplasmic and Nuclear
|
Concept
|
Inflammation Mediators
|
Concept
|
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
|
Concept
|
Epoxy Compounds
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Bradykinin
|
Concept
|
Blood Glucose
|
Concept
|
Fructose
|
Concept
|
Cobalt
|
Concept
|
Cross-Linking Reagents
|
Concept
|
Simvastatin
|
Concept
|
Sodium Channel Blockers
|
Concept
|
NADPH-Ferrihemoprotein Reductase
|
Concept
|
Insulin
|
Concept
|
Hydrochlorothiazide
|
Concept
|
Lactones
|
Concept
|
Large-Conductance Calcium-Activated Potassium Channels
|
Concept
|
Receptor, Endothelin B
|
Concept
|
I-kappa B Kinase
|
Concept
|
Receptor, Bradykinin B2
|
Concept
|
Purinergic P2 Receptor Agonists
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
Concept
|
Fluoresceins
|
Concept
|
Immunologic Factors
|
Concept
|
Indoles
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Matrix Metalloproteinase 9
|
Concept
|
Insulin Receptor Substrate Proteins
|
Concept
|
Hydralazine
|
Concept
|
Indomethacin
|
Concept
|
Hydroxyeicosatetraenoic Acids
|
Concept
|
Hypoglycemic Agents
|
Concept
|
Luteinizing Hormone
|
Concept
|
Metalloendopeptidases
|
Concept
|
Peptidyl-Dipeptidase A
|
Concept
|
Lipids
|
Concept
|
Norepinephrine
|
Concept
|
Immunoglobulin G
|
Concept
|
Oxidoreductases
|
Concept
|
Vasoconstrictor Agents
|
Concept
|
Epithelial Sodium Channels
|
Concept
|
Sodium
|
Concept
|
Pyridines
|
Concept
|
Dinoprostone
|
Concept
|
Superoxides
|
Concept
|
Suramin
|
Concept
|
Receptors, Bradykinin
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Receptors, Angiotensin
|
Concept
|
Chemokines
|
Concept
|
Fatty Acids, Omega-3
|
Concept
|
Receptors, Cannabinoid
|
Concept
|
Receptor, Cannabinoid, CB1
|
Concept
|
Sodium, Dietary
|
Concept
|
Viper Venoms
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
Concept
|
Steroid 16-alpha-Hydroxylase
|
Concept
|
Sodium Chloride, Dietary
|
Concept
|
Phosphoprotein Phosphatases
|
Concept
|
Cell Cycle Proteins
|
Concept
|
Substance P
|
Concept
|
Sulfonamides
|
Concept
|
Arachidonic Acid
|
Concept
|
Cyclooxygenase Inhibitors
|
Concept
|
Pyrrolidines
|
Concept
|
Protein Phosphatase 2
|
Concept
|
Reactive Oxygen Species
|
Concept
|
Apoptosis
|
Concept
|
Losartan
|
Concept
|
Thromboxane B2
|
Concept
|
Receptors, Neurokinin-1
|
Concept
|
Potassium Channels
|
Concept
|
Isoprostanes
|
Concept
|
Tissue Inhibitor of Metalloproteinases
|
Concept
|
Cyclosporine
|
Concept
|
Protective Agents
|
Concept
|
Transforming Growth Factor beta1
|
Concept
|
PPAR alpha
|
Concept
|
Vasodilator Agents
|
Concept
|
Receptors, Leptin
|
Concept
|
Dietary Fats
|
Concept
|
Intercellular Adhesion Molecule-1
|
Concept
|
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
|
Concept
|
Osteonectin
|
Concept
|
Receptors, Purinergic P2
|
Concept
|
Receptors, Prostaglandin E
|
Concept
|
Receptors, Prostaglandin E, EP2 Subtype
|
Concept
|
Nitric Oxide Synthase
|
Concept
|
Cytochrome P-450 CYP1A1
|
Concept
|
Receptor, Adenosine A2B
|
Concept
|
Caspase Inhibitors
|
Concept
|
Vascular Endothelial Growth Factor A
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
Concept
|
Angiotensin II Type 2 Receptor Blockers
|
Concept
|
Inflammasomes
|
Concept
|
Receptor, Cannabinoid, CB2
|
Concept
|
Nitric Oxide Synthase Type III
|
Concept
|
Thiazolidinediones
|
Concept
|
rho-Associated Kinases
|
Concept
|
KATP Channels
|
Concept
|
Transcription Factor RelA
|
Concept
|
Angiotensin Receptor Antagonists
|
Concept
|
Receptors, Prostaglandin E, EP1 Subtype
|
Concept
|
ortho-Aminobenzoates
|
Concept
|
Peptides
|
Concept
|
Phosphates
|
Concept
|
Protein Isoforms
|
Concept
|
Calcium Channels, L-Type
|
Concept
|
Potassium Channels, Calcium-Activated
|
Concept
|
Proto-Oncogene Proteins c-akt
|
Concept
|
Niacinamide
|
Concept
|
Dinoprost
|
Concept
|
Integrins
|
Concept
|
Cytokines
|
Concept
|
Endothelins
|
Concept
|
Okadaic Acid
|
Concept
|
Peroxisome Proliferator-Activated Receptors
|
Academic Article
|
Multi-Target Drugs for Kidney Diseases.
|
Academic Article
|
Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat.
|
Academic Article
|
Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension.
|